These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13425258)

  • 1. Neuropharmacological studies on ibogaine, an indole alkaloid with central-stimulant properties.
    SCHNEIDER JA; SIGG EB
    Ann N Y Acad Sci; 1957 Mar; 66(3):765-76. PubMed ID: 13425258
    [No Abstract]   [Full Text] [Related]  

  • 2. Iboga interactions with psychomotor stimulants: panacea in the paradox?
    Szumlinski KK; Maisonneuve IM; Glick SD
    Toxicon; 2001 Jan; 39(1):75-86. PubMed ID: 10936624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressor and central stimulant properties of a serotonin antagonist.
    MEYERS FH
    Science; 1954 Aug; 120(3111):276-7. PubMed ID: 13186836
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation action of ibogaine (bogadin TM) on morphine analgesia.
    MCARTHUR M; SCHNEIDER JA
    Experientia; 1956 Aug; 12(8):323-4. PubMed ID: 13356821
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with meratran; a new stimulant of the central nervous system].
    FABING HB
    Rev Med Cubana; 1955 Dec; 66(12):923-31. PubMed ID: 13281160
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular and Molecular Mechanisms of Drugs of Abuse: Cocaine, Ibogaine, and Substituted Amphetamines. Proceedings of a conference. Niigata City, Japan, June 29-30, 1995.
    Ann N Y Acad Sci; 1996 Oct; 801():1-452. PubMed ID: 9729221
    [No Abstract]   [Full Text] [Related]  

  • 7. [Central stimulant and depressing pyrimidine derivatives].
    JACOB J
    Experientia; 1951 Sep; 7(9):352-3. PubMed ID: 14879815
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-Ethyl-5-(1,3-dimethyl-2-butenyl) barbituric acid, a potent central nervous system stimulant.
    CAIN CK; KLEIS J
    J Med Pharm Chem; 1959 Feb; 1(1):31-6. PubMed ID: 13655027
    [No Abstract]   [Full Text] [Related]  

  • 9. [5-Phenyl-2-imino-4-oxo-oxazolidine, a central stimulant substance].
    SCHMIDT L
    Arzneimittelforschung; 1956 Aug; 6(8):423-6. PubMed ID: 13373635
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ibogaine - structure, influence on human body, clinical relevance].
    Zdrojewicz Z; Kuszczak B; Olszak N
    Pol Merkur Lekarski; 2016 Jul; 41(241):50-55. PubMed ID: 27734823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-amphetaminic central stimulation by alkaloids from the ibogane an vobasine series.
    Bert M; Marcy R; Quermonne MA; Cotelle M; Koch M
    Planta Med; 1988 Jun; 54(3):191-2. PubMed ID: 2902652
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological actions of a convulsant barbiturate [sodium 5-ethyl-5-(1, 3-dimethylbutyl) barbiturate]. I. Stimulant and depressant effects.
    DOMINO EF; FOX KE; BRODY TM
    J Pharmacol Exp Ther; 1955 Aug; 114(4):473-83. PubMed ID: 13252566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on some pharmacodynamic properties of an indole alkaloid: dregamine. Action on the nervous and muscular systems].
    Albert O; Dupont M; Quirin M
    Ann Pharm Fr; 1970 Dec; 28(12):697-706. PubMed ID: 5516405
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the psychic effect of a central stimulant after various degrees of psychic stress].
    Janke W; Amelang M
    Psychol Forsch; 1965 Dec; 28(6):562-86. PubMed ID: 4380049
    [No Abstract]   [Full Text] [Related]  

  • 15. Central nervous system stimulants.
    VERNIER VG
    Mod Hosp; 1952 May; 78(5):102-10. PubMed ID: 14940983
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga.
    Paškulin R; Jamnik P; Danevčič T; Koželj G; Krašovec R; Krstić-Milošević D; Blagojević D; Strukelj B
    J Ethnopharmacol; 2012 Aug; 143(1):319-24. PubMed ID: 22751004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Nov; 847(1):139-42. PubMed ID: 10564747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of two central nervous system stimulants, MER-22 and S.K.F. #5, on chronic blocked and withdrawn psychotic patients.
    HAGENAUER F; RUDY LH; HIMWICH HE
    Am J Psychiatry; 1957 Mar; 113(9):840. PubMed ID: 13402976
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
    Alburges ME; Hanson GR
    Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL; Hiranita T; Hong WC; Job MO; McCurdy CR
    Handb Exp Pharmacol; 2017; 244():177-218. PubMed ID: 28110353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.